Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
4.770
-0.730 (-13.27%)
At close: Jun 21, 2024, 4:00 PM
4.600
-0.170 (-3.56%)
After-hours: Jun 21, 2024, 5:28 PM EDT

Boundless Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022
Selling, General & Admin
12.169.31
Research & Development
42.6437.16
Operating Expenses
54.846.47
Operating Income
-54.8-46.47
Other Expense / Income
-5.36-0.57
Pretax Income
-49.43-45.9
Net Income
-49.43-45.9
Shares Outstanding (Basic)
11
Shares Outstanding (Diluted)
11
Shares Change
10.75%-
EPS (Basic)
-40.65-41.80
EPS (Diluted)
-40.65-41.80
Free Cash Flow
-47.49-40.66
Free Cash Flow Per Share
-39.05-37.03
EBITDA
-46.12-43.35
Depreciation & Amortization
3.322.55
EBIT
-49.43-45.9
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).